Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 14, Issue 1, pp. 259-269
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted October 3, 2007
- Received June 20, 2007
- Revision received August 31, 2007
- Published first January 2, 2008.
Copyright & Usage
American Association for Cancer Research
Author Information
- Jian Qiao1,
- Hongxun Wang1,
- Timothy Kottke1,
- Christine White3,
- Katie Twigger3,
- Rosa Maria Diaz1,2,
- Jill Thompson1,
- Peter Selby4,
- Johann de Bono3,
- Alan Melcher4,
- Hardev Pandha5,
- Matt Coffey6,
- Richard Vile1,2,4 and
- Kevin Harrington3
- Authors' Affiliations:1Molecular Medicine Program and 2Department of Immunology, Mayo Clinic College of Medicine, Rochester, Minnesota; 3The Institute of Cancer Research, London, United Kingdom; 4Cancer Research UK Clinical Centre, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom; 5Royal Surrey Hospital, Guildford, United Kingdom; and 6Oncolytics Biotech, Inc., Calgary, Alberta, Canada
- Requests for reprints:
Richard G. Vile, Molecular Medicine Program, Mayo Clinic, Guggenheim 1836, 200 1st Street Southwest, Rochester, MN 55902. Phone: 507-284-9941; Fax: 507-266-2122; E-mail: vile.richard{at}mayo.edu.
January 2008
Volume 14, Issue 1
Volume 14, Issue 1
Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus
Jump to section
Advertisement